• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Geron Corp

NASDAQ:GERN

$1.42 $0.03 (2.16%)

REAL-TIME: Last trade at

This Just In: More Upgrades and Downgrades

Geron Narrows Loss on Lower Costs - Analyst Blog

Neutral on Geron Corp. - Analyst Blog

Geron Misses Estimates - Analyst Blog

10 Biotechs Targeting Cancer Stem Cell Destruction

Stem Cell Stocks: Mending Scarred Hearts

Buy, Sell, or Hold: Geron

Don't Bet Against This Biotech IPO

Has GlaxoSmithKline Become the Perfect Stock?

Can Geron Recover in 2012?

The Magic Formula for Biotech

The Worst Health Care Stocks of 2011

Bullish Ideas: Short-Sellers Think These Cash-Rich Companies Have More Upside

Geron's Hurry-Up-and-Wait Strategy

Health Care's Worst Stocks 2011: Dendreon

Whoa! My Stock Just Whupped the Market!

What's Up With the Back-Slapping, Sequenom?

If You Can't Beat 'Em, Join 'Em: Amgen Goes Generic

Has Geron Become the Perfect Stock?

In Drug Development, Help Is Crucial

Breaking Down a Biotech Press Release

Whoa! My Stock Just Crushed the Market!

5 Stocks Under $10

Market Volatility = Biotech Opportunity

Tomorrow's Monster Stock

This Just In: More Upgrades and Downgrades

The Market Just Crushed My Stock!

Stem Cell Therapy May Prevent Heart Failure: 4 Companies to Watch

3 Biotechs Beating the Market

Geron Falls After Scrapping Stem Cell Program

When Giving Up Is a Good Move in Biotech

Contradictions in Investing: When Big Is Bad

Just Say No -- and Make More Money

5 Stocks Under $10

5 Stocks Under $10

5 Superball Stocks

Wall Street's Wrong About These Stocks

5 Superball Stocks

Stem-Cell Stocks May Now Be Worth The Risk

Medical Breakthrough: Successful Stem Cell Transplant in Sweden

See More Articles...